Real-world outcomes of talimogene laherparepvec as salvage therapy for advanced melanoma

Background Talimogene laherparepvec (T-VEC) is an oncolytic herpes simplex virus therapy approved for treatment of unresectable and metastatic melanoma. However, real-world use often occurs in heavily pretreated patients, where evidence of effectiveness remains limited. This study evaluates treatmen...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Shailender Bhatia, Paul T Nghiem, George Ansstas, Song Y Park, Coley Doolittle-Amieva, Evan T Hall, Melissa M Yamada, Smitha Chandrasekhar, Ted A Gooley, Rita E Chen, David Y Chen
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2025-12-01
סדרה:	Journal for ImmunoTherapy of Cancer
גישה מקוונת:	https://jitc.bmj.com/content/13/12/e013564.full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!